SCHEMBL2369862

SCHEMBL2369862

c1coc(NC2CC2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6534546 0.86 ADORA2A (0.42)
SCHEMBL21047589 0.85 KMT2A (0.36)
SCHEMBL976980 0.69 TP53 (0.41)
SCHEMBL4935890 0.67
SCHEMBL84841 0.67
SCHEMBL2845839 0.65
SCHEMBL6427468 0.65
Hydrochloric Acid SCHEMBL29184275 0.65
Bromide SCHEMBL28393345 0.65
Hydrochloric Acid SCHEMBL28392789 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103442568-A Furo [3,2-d ] pyrimidine compounds ABBVIE INC 2013-12-11 CN claimed
CN-103442568-A Furo [3,2-d ] pyrimidine compounds ABBVIE INC 2013-12-11 CN disclosed
EP-2545042-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Bristol-Myers Squibb Company (US) 2013-01-16 EP disclosed
WO-2011112191-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2011-09-15 WO disclosed